1.79
-0.03(-1.65%)
Currency In USD
| Previous Close | 1.82 |
| Open | 1.79 |
| Day High | 1.86 |
| Day Low | 1.72 |
| 52-Week High | 3.79 |
| 52-Week Low | 1.72 |
| Volume | 26,716 |
| Average Volume | 24,196 |
| Market Cap | 7.47M |
| PE | -0.79 |
| EPS | -2.27 |
| Moving Average 50 Days | 2.18 |
| Moving Average 200 Days | 2.64 |
| Change | -0.03 |
If you invested $1000 in STRATA Skin Sciences, Inc. (SSKN) 10 years ago, it would be worth $30.6 as of August 18, 2025 at a share price of $1.79. Whereas If you bought $1000 worth of STRATA Skin Sciences, Inc. (SSKN) shares 5 years ago, it would be worth $101.7 as of August 18, 2025 at a share price of $1.79.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
STRATA Skin Sciences Moves to Accelerate Medicare and Private Payer Coverage from Expanded CPT Code Expansion, Tripling Addressable Market to 30M+ Patients
GlobeNewswire Inc.
Aug 07, 2025 12:15 PM GMT
Peer-reviewed publications continue to validate Excimer Laser efficacy in vitiligo and treatment STRATA updates status of non-Excimer laser false advertising litigation HORSHAM, Pa., Aug. 07, 2025 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (“
STRATA Skin Sciences to Report Second Quarter 2025 Financial Results on August 13, 2025 and Provide Corporate Update
GlobeNewswire Inc.
Jul 31, 2025 12:15 PM GMT
HORSHAM, Pa., July 31, 2025 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing, and marketing innovative products for the treatment of der
STRATA Skin Sciences Announces Historic Expansion of CPT Codes for Reimbursement of 308nm Excimer Laser Treatments, Unlocking Access for Millions with Inflammatory and Auto-Immune Skin Diseases
GlobeNewswire Inc.
May 19, 2025 12:00 PM GMT
HORSHAM, Pa., May 19, 2025 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (NASDAQ: SSKN), a medical technology company dedicated to advancing dermatologic care through innovation, announces that the American Medical Asso